 Use azathioprine treatment Crohn disease efficacy safety therapy patients Crohn disease Mean duration therapy years patients equal months patients antiinflammatory medications Evaluations self-assessment physician assessment well-being functional capacity general clinical response clinical activities indices National Foundation Ileitis Colitis/International Organization Study Inflammatory Bowel Disease Harvey-Bradshaw achievement specific therapeutic goals General clinical condition patients Median response time months average Harvey-Bradshaw score therapy decrease equal subjects overall achievement rate therapeutic goals refractory disease corticosteroid sparing fistulization patients therapy Adverse effects discontinuation therapy whereas dosages briefly mild side effects study effectiveness safety majority patients chronic unremitting steroid-requiring Crohn disease